CHUGAI PHARMACEUTICAL CO., LTD.

Print

Translation

Jul 27, 2017

Name of listed company:   Chugai Pharmaceutical Co., Ltd.
Code number: 4519 (1st Section of Tokyo Stock Exchange)
Head office: 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo
Chairman & CEO: Osamu Nagayama
Inquiries to: Masahiko Uchida,
General Manager, Corporate Communications Dept.
  Tel:+81-(0)3-3273-0881

F. Hoffmann-La Roche Announces Half Year Results 2017

F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its half year results 2017 (January 1 – June 30, 2017).
Roche owns 59.89% of Chugai's outstanding shares (61.32% of the total number of shares issued excluding treasury stock) as of end of June 2017.
Its press release and presentation materials can be found on its website (http://www.roche.com).
Chugai’s performance for the period of January 1 to June 30, 2017 is included in the announced Roche Group’s results.

Media Releases Investor Updates Presentation Half-Year Report 2017

[ PDF 76KB]

To view PDF files,
you will need Adobe® Reader® which is available as a free download.

Close